HCPCS code J9011 — Datopotamab deruxtecan, 1 mg. Status: Active. Effective Oct 1, 2025. Source: CMS HCPCS Level II.

J9011

Active

Datopotamab deruxtecan, 1 mg

Injection, datopotamab deruxtecan-dlnk, 1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Oct 1, 2025
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 0835

MUE — Medically Unlikely Edits

Maximum units of J9011 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 600
Practitioner Services 600

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
65597-0801-01 Datroway

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2025-Q4
    Datopotamab deruxtecan, 1 mg